Cleared Traditional

K884359 - UNIT DOSE 3% SODIUM CHLORIDE SOLUTION F...

K884359 is an FDA 510(k) clearance for UNIT DOSE 3% SODIUM CHLORIDE SOLUTION F..., manufactured by Automatic Liquid Packaging, Inc.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 64-day FDA review.

K884359 · Automatic Liquid Packaging, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1988
Decision
64d
Days
Class 2
Risk

K884359 is an FDA 510(k) clearance for the UNIT DOSE 3% SODIUM CHLORIDE SOLUTION FOR INHALA.. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Automatic Liquid Packaging, Inc. (Woodstock, US). The FDA issued a Cleared decision on December 20, 1988 after a review of 64 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Automatic Liquid Packaging, Inc. devices

FDA 510(k) Submission Details - K884359

510(k) Number K884359 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 17, 1988
Decision Date December 20, 1988
Days to Decision 64 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 140d · This submission: 64d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 218
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K884359.
HAND HELD NEBULIZER SYSTEM
K884947 · Salter Labs · Feb 1989
ADJUSTABLE ENTRAINMENT NEBULIZER
K882936 · Automatic Liquid Packaging, Inc. · Jan 1989
NEBULIZER HEATER
K882935 · Automatic Liquid Packaging, Inc. · Dec 1988
OMRON ULTRASONIC NEBULIZER NE-U06
K875134 · Nidek, Inc. · Dec 1988
AIRLIFE MISTY NEB MEDICATION SYSTEM W/FILTER
K883964 · Baxter Healthcare Corp · Nov 1988
MICROCIRRUS MEDICAL NEBULIZER
K881935 · Dhd Medical Products Div. Diemolding Corp. · Jun 1988